Requires certain health insurance to cover certain health care related to severe obesity. (BDR 57-657)
AB 399 would require a broad set of Nevada health coverage arrangements to include medically necessary treatment and care for diseases and conditions caused by severe obesity. The bill applies to individual and group health insurance policies, health benefit plans, hospital and medical services corporation policies, health maintenance organization plans, managed care plans, certain public employee coverage, and Medicaid, subject to federal funding and waiver requirements for Medicaid. Covered services include medically necessary bariatric surgery for adults age 18 and older, along with related preoperative and postoperative services such as psychological screening, counseling, behavior modification, physical therapy, and nutritional education.
The bill defines severe obesity as a body mass index of 40 or higher, or 35 or higher with an associated comorbidity such as hypertension, cardiopulmonary conditions, sleep apnea, or diabetes. It allows insurers and plans to impose certain utilization controls, including a preoperative period of up to three months, a requirement that surgery be performed in an accredited facility, a written medical-necessity statement, and a limit of one bariatric surgery per lifetime. The bill expressly excludes coverage for weight-loss drugs, including injectable glucose-lowering drugs used for weight loss, and it would apply to policies and plans delivered, issued, or renewed on or after January 1, 2026.
AB 399 would amend multiple chapters of Nevada insurance law and Medicaid law to create a new mandated-benefit category for severe obesity treatment. It would add coverage requirements across private insurers, group plans, health benefit plans, HMOs, managed care organizations, and public employee/self-insured arrangements, while also authorizing the Insurance Commissioner to enforce compliance and, in some cases, to require domestic insurers to include the new coverage in policies issued to out-of-state residents. For Medicaid, the Department of Health and Human Services would have to seek any needed federal waiver or state plan amendment to secure federal financial participation. The bill also contains an unfunded mandate provision for local governments and takes effect in stages, with administrative authority immediately upon passage and coverage requirements beginning January 1, 2026.
Based on the bill text and the absence of recorded committee testimony or votes in the provided materials, the overall sentiment appears to be supportive or at least policy-driven rather than contested in the available record. The measure is framed as a coverage expansion for medically necessary treatment of a serious health condition, while also including multiple insurer-friendly limitations and exclusions that suggest an effort to balance access with cost control. No formal vote history or transcript discussion is provided to indicate organized opposition or amendment debate.
The main points of potential contention are likely cost, scope, and implementation. Insurers, employers, and local governments may object to the mandate because the fiscal note indicates possible state and local fiscal impact and the bill contains an unfunded mandate. Coverage of bariatric surgery for adults with severe obesity may also raise questions about medical necessity standards, prior authorization, facility accreditation, and the one-surgery-per-lifetime cap. On the other hand, advocates for obesity treatment may view the exclusion of weight-loss drugs as too narrow, while payers may view any required coverage expansion as too broad. Medicaid implementation could also be contentious because it depends on federal approval and funding.